Key Methodological Considerations in the Interpretation of the CONKO-007 Trial
O
Orhun Akdogan
A
Ahmet Özet
O
Ozan Yazıcı
N
Nuriye Özdemir
O
Osman Sütcüoglu
(Orhun Akdogan, MD; Ahmet Ozet, MD; Ozan Yazıcı, MD; Nuriye Ozdemir, MD; and Osman Sütcüoglu, MD, Department of Medical Oncology, Gazi University, Ankara, Turkey)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 44, Issue 20
Published
July 10, 2026
Pages
1950-1951
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (5)
O
Orhun Akdogan
A
Ahmet Özet
O
Ozan Yazıcı
N
Nuriye Özdemir
O
Osman Sütcüoglu
Orhun Akdogan, MD; Ahmet Ozet, MD; Ozan Yazıcı, MD; Nuriye Ozdemir, MD; and Osman Sütcüoglu, MD, Department of Medical Oncology, Gazi University, Ankara, Turkey
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001